Biofrontera Inc. Capital Expenditures
Biofrontera Inc. (BFRI) reported Capital Expenditures of $5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Biofrontera Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Biofrontera Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $5.00K, a 66.67% increase year-over-year.
- Biofrontera Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was -$1.00K, a 200.00% decline year-over-year.
- Biofrontera Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was -$1.00K.
- Biofrontera Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $2.00K, a 80.00% decline from fiscal 2024.
- Biofrontera Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $10.00K, a 100.00% increase from fiscal 2023.
- Biofrontera Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $5.00K, a 86.84% decline from fiscal 2022.
- Biofrontera Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $38.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.00K 10-Q · filed 2026-08-13 | $4.00K derived: sum of 3 quarters · filed 2026-08-13 | $3.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-14 | $4.00K derived: sum of 2 quarters · filed 2026-05-14 | $3.00K derived: sum of 3 quarters · filed 2026-05-14 | $4.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$2.00K derived: sum of 2 quarters · filed 2026-03-19 | -$1.00K derived: sum of 3 quarters · filed 2026-08-13 | $2.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $3.00K 10-Q · filed 2025-11-12 | $4.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.00K 10-Q · filed 2026-08-13 | $5.00K derived: sum of 3 quarters · filed 2026-08-13 | $5.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-14 | $4.00K derived: sum of 2 quarters · filed 2026-05-14 | $4.00K derived: sum of 3 quarters · filed 2026-05-14 | -$44.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.00K derived: sum of 2 quarters · filed 2026-03-19 | -$47.00K derived: sum of 3 quarters · filed 2026-03-19 | $10.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$48.00K derived: sum of 2 quarters · filed 2025-11-12 | $9.00K 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $9.00K 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $57.00K 10-Q · filed 2025-05-15 | $48.00K derived: sum of 2 quarters · filed 2025-05-15 | $48.00K derived: sum of 3 quarters · filed 2025-05-15 | $48.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$9.00K derived: sum of 2 quarters · filed 2025-03-20 | -$9.00K derived: sum of 3 quarters · filed 2025-03-20 | $5.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $14.00K 10-Q · filed 2024-11-14 | $15.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $14.00K 10-Q · filed 2024-08-14 | $15.00K derived: sum of 3 quarters · filed 2024-08-14 | $16.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-15 | $15.00K derived: sum of 2 quarters · filed 2024-05-15 | $16.00K derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $2.00K derived: sum of 2 quarters · filed 2024-03-15 | $38.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $37.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $36.00K 10-Q · filed 2023-08-11 | |||
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |